EUVIMEDObjevte EUVIMED
Open access · CC BY-NC-ND 4.0

The Role of the Sirt1/Foxo3a Pathway in Mitigating Myocardial Ischemia–Reperfusion Injury by Dexmedetomidine

Hanlin Ding, Danyong Liu, Jianfeng He, Dongcheng Zhou, Chan Wang, Changming Yang, Zhongyuan Xia

Chemical Biology & Drug Design · 2025

DOI: 10.1111/cbdd.70100 ↗

At a glance

Journal article in Chemical Biology & Drug Design, 2025. Written by Hanlin Ding and 6 co-authors. Institution: Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China. Major MEDLINE topics: Dexmedetomidine, Forkhead Box Protein O3, Myocardial Reperfusion Injury, Sirtuin 1. Cited 3 times so far (Crossref); 51 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: The National Science Foundation of China, National Natural Science Foundation of China.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Myocardial ischemia–reperfusion injury (MIRI) significantly affects the prognosis of cardiac surgery patients. The anesthetic dexmedetomidine (Dex) has shown protective effects against ischemia–reperfusion injury in cardiomyocytes; however, its exact mechanism remains unclear. In this study, hypoxia/reoxygenation (H/R) and ischemia/reperfusion (I/R) models were used to investigate the effects of Dex on H9c2 cells and MIRI in mice. The roles of the Sirtuin 1/Forkhead box O3a (Sirt1/FoxO3a) pathway in the protective effects of Dex were explored using the Sirt1 inhibitor EX527 and FoxO3a gene silencing. Results showed that H/R significantly reduced H9c2 cell viability, increased Lactate Dehydrogenase (LDH) leakage, and elevated reactive oxygen species (ROS) production. Dex pretreatment reversed these effects. Additionally, Dex significantly reduced the expression of Bcl‐2‐associated X protein/B‐cell lymphoma 2 (Bax/Bcl‐2), cleaved caspase‐3, Beclin‐1, and microtubule‐associated protein 1A/1B‐light chain 3B (LC3B), inhibiting apoptosis and autophagy while increasing the expression of p62, Sirt1, and FoxO3a. The protective effects of Dex against H/R injury were abolished by EX527 or FoxO3a silencing. In the mouse MIRI model, Dex pretreatment decreased serum LDH and Creatine Kinase‐MB (CK‐MB) levels, reduced myocardial infarct size and cardiac injury, and significantly improved left ventricular ejection fraction (LVEF) and left ventricular fractional shortening (LVFS). These protective effects were markedly reversed by EX527. These findings indicate that Dex alleviates MIRI by restoring Sirt1 expression and activating FoxO3a.

Subjects

MeSH terms (MEDLINE)

DexmedetomidineForkhead Box Protein O3Myocardial Reperfusion InjurySirtuin 1AnimalsMaleMiceRatsApoptosisAutophagyCell LineCell SurvivalMice, Inbred C57BLMyocytes, CardiacReactive Oxygen SpeciesSignal TransductionMicrotubule-Associated ProteinsCarbazoles

Author keywords

FoxO3aSirt1apoptosisautophagydexmedetomidinemyocardial ischemia–reperfusion injury

Substances

6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamideDexmedetomidineForkhead Box Protein O3FoxO3 protein, mouseReactive Oxygen SpeciesSirt1 protein, mouseSirtuin 1Map1b protein, mouseMicrotubule-Associated Proteinsmicrotubule-associated protein 1B

Authors and institutions

  • Department of Anesthesiology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
  • Department of Anesthesiology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China.
  • Shenzhen Institute of Research and Innovation, the University of Hong Kong, Shenzhen, China.
  • Department of Anesthesiology, The First People's Hospital of Jingmen City, Jingmen, Hubei, China.

Funding

  • The National Science Foundation of China
  • National Natural Science Foundation of China

Cite

APA

Ding, H., Liu, D., He, J., Zhou, D., Wang, C., Yang, C., & Xia, Z. (2025). The Role of the Sirt1/Foxo3a Pathway in Mitigating Myocardial Ischemia–Reperfusion Injury by Dexmedetomidine. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70100

Vancouver

Ding H, Liu D, He J, Zhou D, Wang C, Yang C, et al. The Role of the Sirt1/Foxo3a Pathway in Mitigating Myocardial Ischemia–Reperfusion Injury by Dexmedetomidine. Chemical Biology & Drug Design. 2025. doi:10.1111/cbdd.70100

BibTeX
@article{Ding2025,
  author = {Ding, Hanlin and Liu, Danyong and He, Jianfeng and Zhou, Dongcheng and Wang, Chan and Yang, Changming and Xia, Zhongyuan},
  title = {The Role of the Sirt1/Foxo3a Pathway in Mitigating Myocardial Ischemia–Reperfusion Injury by Dexmedetomidine},
  journal = {Chemical Biology & Drug Design},
  year = {2025},
  doi = {10.1111/cbdd.70100}
}
Start for free →